Press Releases MCRA Assists NeuroMetrix with Obtaining FDA Breakthrough Device Designation and Marketing Authorization in One Year Read Article Jul — 2022
Press Releases MCRA and Clients Achieve Significant Milestone - Over 60 Breakthrough Device Designations Granted by FDA Read Article Jun — 2022
Press Releases MCRA Assists BONESUPPORT AB with the First Ever Combination Product DeNovo Decision Granted by the U.S. FDA Read Article Jun — 2022
Press Releases MCRA Assists Net Health in Receiving Breakthrough Device Status Read Article Jun — 2022
Press Releases MCRA Acquires Vorpal Technologies K.K. to Further Expand its Global Advisory Services in Japan Read Article Mar — 2022
Publications Risk Management is critical to establishing a positive benefit: risk profile and ensuring the best possible patient outcomes. By: Peter Bowness Director, International Regulatory Affairs Read Article Jan — 2022
Press Releases MCRA Assists Active Life Scientific with Clinical Study Execution and Successful De Novo Decision for the OsteoProbe - A New Tool to Measure Bone Tissue Read Article Jan — 2022
Press Releases MCRA Assists Multiple Clients with Successfully Obtaining CPT Codes and Hospital Payment Reassignments Read Article Jan — 2022
Press Releases MCRA Expands Neurology Division into Medical Robotics, Exoskeletal and Brain Computer Interface Market Read Article Oct — 2021
Press Releases MCRA Hires Melissa Paper, JD, MPA, CHC as Vice President of Healthcare Compliance Read Article Oct — 2021
Press Releases MCRA Expands Neurology Division into Neurointerventional Market Read Article Sep — 2021
Webinars Considerations for Orthopedic Implant Associated Antimicrobial Agents: Regulatory Science Read Article Jun — 2021